AI

Leadership Shake-Up at INFINITT Europe as Kevin Lim Takes Charge

The transition marks the end of an unusually long era of stability and raises questions about the company’s future direction in Europe’s competitive medical imaging market.

AI in Mammography: Lunit Expands Across French Hospitals

Lunit’s AI solutions for mammography and digital breast tomosynthesis are now available to over 1,500 French public hospitals through a four-year framework agreement with UniHA and partner Fujifilm.

Brainomix Stroke AI Software Hailed as ῾Revolutionary,’ Helping More Patients Fully Recover

Lunit Selected as Exclusive AI Partner for Spain’s Valencian Community Breast Screening Program

Milestone European deployment underscores growing global trust in Lunit’s AI for population-wide breast cancer screening

FDA Clears AI-Guided Ultrasound Device for Liver Disease

The U.S. FDA has granted 510(k) clearance to Sonic Incytes’ Velacur ONE, an AI-guided point-of-care ultrasound elastography device designed to support the diagnosis and management of chronic liver diseases including MASH and MASLD.

Calidar Reports First 4D Mammography Imaging System

Calidar has reported the first patient imaging with its investigational 4D Mammography system.

Lunit’s AI Screens Cancer for Italy’s Population

With deployments in Lazio, Lombardia, and Veneto regions, Lunit strengthens its foothold in one of Europe’s largest public healthcare systems

RSNA AI Challenge Models Interprets Mammography Screening

AI models developed during the RSNA Screening Mammography Breast Cancer Detection Challenge showed strong performance in breast cancer detection.

Pediatric Imaging Market to Double in Value Over Next Decade

The pediatric imaging market is expected to more than double in value by 2034, made possible by advances in low-dose and AI-powered imaging.

3 Ways AI is Enhancing Diagnostic Imaging

From faster diagnoses to greater accuracy, AI helps improve diagnostic imaging.

FDA Grants Clearance for DeepHealth’s TechLive™

DeepHealth has received FDA 510(k) clearance for TechLive™, a vendor-agnostic remote scanning solution.

AI-QUAL: First AI Module for Automated Prostate MRI Quality Scoring

Quibim launches AI-QUAL to standardize prostate MRI quality assessment and support more accurate prostate cancer diagnostics

Röko 2025: mediaire Demonstrates AI for Prostate Diagnostics

AI Supports Full Patient Journey and Fusion Biopsy

RöKo 2025: Annalise.ai Highlights Comprehensive AI for Radiology

Chest X-Ray and Head CT Solutions Covering 124 Pathologies

RöKo 2025: AIRS Medical Showcases AI Innovation in MRI

Improving MRI Efficiency and Image Quality with AI-Based Solution

RöKo 2025: Intrasense Introduces AI Solutions for Oncology Imaging

Advanced Visualization and AI for Prostate Cancer and Lung Nodules

RöKo 2025: Floy Unveils Opportunistic Screening AI

Detecting hidden diseases in routine CT scans

RadNet Acquires See-Mode Technologies to Advance AI in Ultrasound Imaging

RadNet has confirmed the acquisition of See-Mode Technologies PTE LTD, a global innovator in artificial intelligence (AI) for ultrasound imaging. The move marks a significant expansion of RadNet's capabilities in AI-powered diagnostic imaging.

Could AI help people live longer, healthier lives?

If you ask most people to define healthcare, they’ll likely describe what happens after someone becomes sick and begins receiving care. But could healthcare begin before illness ever showed up?

Lunit Expands AI Solutions for Chest and Breast Imaging

New chest imaging AI and growing partnerships in Germany

Avicenna.AI Secures CE Mark for Two Spine-Focused Medical Imaging AI Tools

European certification clears the way for clinical deployment of AI solutions for vertebral and cervical spine fracture detection

VENUS: First software module combining AI and computational modelling to support aortic aneurysm diagnosis

LivGemini introduces VENUS, a hybrid solution for personalised cardiovascular medicine based on CT imaging and in-silico simulation

Lunit INSIGHT CXR4 Gains CE-MDR Certification, Expands AI Capabilities for Chest Imaging

Next-gen solution introduces new findings, enhanced workflow tools, and European market readiness

Bayer Launches Centafore™ Imaging Core Lab to Support Imaging for Clinical Trials and Software as a Medical Device Development

New imaging CRO offers full-spectrum services from early research to Phase IV trials and SaMD development across multiple therapeutic areas

Brainomix Appoints Khush F. Mehta as Chair to Support Global Expansion and Commercial Growth

Guelph General Hospital adds digital pathology to cloud service from Sectra—enables integrated diagnostics for improved patient care

First in Canada to implement Sectra’s digital pathology module within a cloud-based enterprise imaging system

A new era for ultrasound’: European healthcare professionals react to new ultrasound technology

Experts highlight diagnostic breakthroughs and workflow benefits enabled by Mindray’s Resona A20 premium ultrasound system

Lunit to Power Germany’s Largest Private Radiology Network with AI Imaging

Five-year agreement enables large-scale deployment of AI diagnostic tools across 79 Starvision sites nationwide

Sectra’s fully managed AI offering extended to include pathology following new Amplifier partner agreement

Unified AI Platform Expands to Pathology Through Strategic Partnership with Paige.AI

RadNet and iCAD Unite to Revolutionize AI-Driven Breast Cancer Detection

Strategic Alliance to Enhance Early Detection and Global Access through AI

Transforming Lung Cancer Screening with AI

AI and cloud tech revolutionize lung cancer screening

Generative AI on the rise

Mindray - next level ultrasound imaging at ECR 2025

Mindray presented its ‘Reveal What Matters’ concept at the European Congress of Radiology (ECR) in Vienna

Putting Patients First Beyond the Scan: Bayer at ECR 2025

Bayer at ECR 2025: Shaping Radiology with Contrast & AI

DeepHealth drives screening efficiency, impact

How the company has evolved from a small player to a leading provider of AI-driven imaging solutions

ECR 2025 Shines a Spotlight on Next-Generation Imaging Innovations

SOLACE aims to improve lung cancer screening

Positive results from Phase III study for Bayer’s investigational contrast agent gadoquatrane

EUCAIM: European AI initiative for more precise cancer medicine

Quibim announces $50 million in Series A financing led by Asabys and Buenavista, to revolutionize precision medicine with AI-Powered imaging biomarkers

AI in radiology: driving innovation for more precise diagnostics and better patient care

Breast cancer diagnostics: technical possibilities are not yet being used sufficiently

ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities

Integration of Biomediq Enhances Transpara® Platform for More Precise Risk Stratification and Personalized Breast Cancer Screening

SIRM2024: Giovagnoni on AI and Next Generation Radiology

At SIRM2024, Mélisande Rouger asked Prof. Andrea Giovagnoni ...

The Brand New World of Fully Digitized Pathology